In 2020, the first year of the COVID-19 pandemic, dementia was the dominant risk factor for the disease among residents of Swedish nursing homes. This…
Nearly two dozen experimental therapies targeting the immune system are in clinical trials for Alzheimer’s disease, a reflection of the growing recognition that immune processes…
Dementia in India may be higher than previous estimates have suggested and could be more in line with prevalence rates for countries such as the…
Alzheimer’s disease is the most common neurodegenerative disease in people over 65 and affects more than 50 million people worldwide—a number that is expected to…
In a large study of diverse adults in California, individuals with newly diagnosed atrial fibrillation, or an irregular heart rhythm, had a modestly elevated risk…
Reducing the methylation of a key messenger RNA can promote migration of macrophages into the brain and ameliorate symptoms of Alzheimer’s disease in a mouse…
Extra virgin olive oil may have positive effects on individuals with mild cognitive impairment, according to a recently completed study by Amal Kaddoumi in Auburn…
Adding to the growing body of evidence on sleep disturbances and cognitive impairment, new research finds significant links between three measures of sleep disturbance and…
Cedars-Sinai investigators have produced the most extensive analysis to date of changes in the retina—a layer of tissue at the back of the eye where…
America’s aging population means that more families are soon going to be grappling with a heartbreaking issue—a loved one living with dementia who then develops…